<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05015400</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00014289</org_study_id>
    <nct_id>NCT05015400</nct_id>
  </id_info>
  <brief_title>Female Urogenital Nutrition- Health Study</brief_title>
  <acronym>FUN-Health</acronym>
  <official_title>Female Urogenital Nutrition- Health Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Arizona State University Graduate and Professional Student Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess nutrition and urinary tract bacterial activity during&#xD;
      menstruation of approximately 15 female university Reserve Officer Training Corps (ROTC)&#xD;
      cadets and Phoenix area police officers, firefighters, and military veterans.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Urinary tract infections (UTIs) disrupt tactical service women's obligations and health,&#xD;
      which increases sexual transmitted infections (STIs), HPV, and cervical cancer risk if left&#xD;
      untreated. Females are more susceptible to UTIs due to their unique anatomical features and&#xD;
      hormone fluctuations affecting vaginal flora. During phase 1 of the menstrual cycle (i.e.,&#xD;
      onset of bleeding, menstrual cycle days 1-5), estrogen levels significantly decrease and&#xD;
      inhibit the growth of lactobacilli (good bacteria), which is essential in warding off bad&#xD;
      bacteria and infections, particularly UTIs. The uropathogenic bacterial growth in phase 1&#xD;
      could be heightened in phase 2 of the menstrual cycle (i.e., leading to ovulation), as&#xD;
      increases in estrogen favors bacteria adhesion and arginine vasopressin (AVP) release that&#xD;
      stimulates fluid retention, leading to less volume flow in the urinary tract. To reduce UTI&#xD;
      onset, it is recommended to frequently urinate with sufficient urine void volume to&#xD;
      facilitate washing out harmful bacteria from the urethra and bladder. While menstruating,&#xD;
      increased fluid consumption to support urination frequency and void volume may be critical,&#xD;
      as the urinary tract is more predisposed to infections, and the effects of estrogen on&#xD;
      bacterial adhesion and AVP release in phase 2 could continue uropathogenic growth.&#xD;
&#xD;
      Question(s) 1: Are premenopausal tactical service women's current hydration status and&#xD;
      behaviors (i.e., fluid intake and urination) sufficient? How many premenopausal tactical&#xD;
      service women have a UTI history?&#xD;
&#xD;
      Question 2: Will increasing daily water intake of identified underhydrated tactical service&#xD;
      women reduce uropathogenic bacterial activity during the first part (i.e., onset of bleeding&#xD;
      through day 5) of the menstrual cycle?&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uropathogenic Bacterial Activity</measure>
    <time_frame>Change from Baseline Uropathogenic Bacterial Activity at 1 month</time_frame>
    <description>Number of bacterial colonies and uropathogens found</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hydration Status</measure>
    <time_frame>Change from Baseline Hydration Status at 1 month</time_frame>
    <description>Urine concentration via urine specific gravity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Bacterial Urinary Tract Infection</condition>
  <arm_group>
    <arm_group_label>Fluid Increase</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The increased fluid intervention arm will begin on day 2 after the onset of bleeding (day 1) of their phase 1 menses through day 5. For the increased fluid intake intervention, participants will a) consume an additional 64 oz (1.89 L) of plain water only on top of habitual fluid intake and b) aim to at least urinate 5 times per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fluid Habitual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The fluid habitual non-intervention arm will a) maintain normal fluid intake volume and beverage choices and a) urination frequency.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Plain Water</intervention_name>
    <description>To increase water fluid intake, an additional 1.89 L, during phase 1 of the menstrual cycle (days 1-5).</description>
    <arm_group_label>Fluid Increase</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female university ROTC cadets, military veterans attending, police officers, and&#xD;
             firefighters.&#xD;
&#xD;
          -  18-34 years of age or older (premenopausal)&#xD;
&#xD;
          -  Have a 21-35-day menstrual cycle&#xD;
&#xD;
          -  No changes in hormonal contraceptives within the last three months&#xD;
&#xD;
          -  No current UTI symptoms&#xD;
&#xD;
          -  Sexual activity and inactivity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Males&#xD;
&#xD;
          -  Under 18 years of age or over 34 years of age&#xD;
&#xD;
          -  Pregnant or nursing&#xD;
&#xD;
          -  Menstrual irregularities effecting having a menstrual cycle to be between 21-35 days&#xD;
&#xD;
          -  Progesterone-only contraceptive use (combined estrogen-progesterone and non-hormonal&#xD;
             IUDs are okay)&#xD;
&#xD;
          -  Currently taking antibiotics&#xD;
&#xD;
          -  On hormone replacement therapy&#xD;
&#xD;
          -  Currently experiencing symptomatic vulvovaginitis&#xD;
&#xD;
          -  Diagnosed with recurrent UTI&#xD;
&#xD;
          -  Not volunteering to participate&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>34 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaila A Vento, PhD(c)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaila A Vento, PhD(c)</last_name>
    <phone>6199877595</phone>
    <email>kvento@asu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Floris C Wardenaar, PhD</last_name>
    <phone>602-827-2841</phone>
    <email>fwardena@asu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona State University</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 9, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Arizona State University</investigator_affiliation>
    <investigator_full_name>Kaila Vento</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Starting 6 months after publication.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

